Published September 2021 | Version v1
Journal article

Thymidylate synthase is essential for efficient HIV-1 replication in macrophages

  • 1. Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche Du CHU de Québec-Université Laval, Pavillon CHUL, Québec, QC, G1V 4G2 (Canada)
  • 2. Département de Microbiologie-infectiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, QC, G1V 0A6 (Canada)

Description

Highlights: • Macrophages could serve as long-lived compartments for HIV-1 infection. • Numerous host factors can modulate the life cycle of HIV-1. • Thymidylate synthase can be seen as a regulator of HIV-1 replication in human macrophages. Thymidylate synthase (TS) is a key enzyme in nucleotide biosynthesis. A study performed by our group on human monocyte-derived macrophages (MDMs) infected with HIV-1 showed that many enzymes related to the folate cycle pathway, such as TS, are upregulated in productively infected cells. Here, we suggest that TS is essential for an effective HIV-1 infection in MDMs. Indeed, a TS specific small interfering RNA (siRNA) as well as the TS specific inhibitor Raltitrexed (RTX) caused a reduction in productively infected cells. Quantitative PCR analysis showed that this treatment decreased the efficacy of the early steps of the viral cycle. The RTX inhibitory effect was counteracted by dNTP addition. These results suggest that TS is essential for the early stages of HIV-1 infection by providing optimal dNTP concentrations in MDMs. TS and its related pathway may thus be considered as a potential therapeutic target for HIV-1 treatment.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.virol.2021.05.002

Additional details

Identifiers

DOI
10.1016/j.virol.2021.05.002;
PII
S0042682221001069;

Publishing Information

Journal Title
Virology (New York, N.Y. Print)
Journal Volume
561
Journal Page Range
p. 47-57
ISSN
0042-6822
CODEN
VIRLAX

Optional Information

Copyright
Copyright (c) 2021 Elsevier Inc. All rights reserved.